Cardiovascular Disease· Topic 2.7 Myocardial disease· 2.7.1

Heart failure

Heart failure is a clinical syndrome of impaired cardiac filling or ejection causing congestion and reduced perfusion, classified by ejection fraction. Diagnosis integrates symptoms, signs, natriuretic peptides, and echocardiography, and treatment of reduced-ejection-fraction disease is quadruple guideline-directed therapy, with device therapy and cause-specific management.

6 min read24 practice questions7 key factsSubscriber article
  • Topic review
    The full article, organized the way the exam asks it.
  • ABIM-format MCQs
    Vignettes with an explanation for every wrong answer.
  • Key facts
    The numbers and thresholds worth memorizing, up front.
  • AI tutor
    MedBrain answers the question you're stuck on.

What this article covers

  • Overview

    Definition: heart failure is a clinical syndrome in which impaired cardiac filling or ejection produces congestion and inadequate tissue perfusion.

  • Epidemiology

    Common and increasing with an aging population.

  • Risk factors

    Coronary artery disease and prior myocardial infarction (the leading cause of HFrEF).

  • Pathophysiology

    Impaired pump or filling: systolic dysfunction reduces ejection, while diastolic dysfunction impairs filling at normal ejection fraction.

  • Clinical features

    Exertional dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.

  • Differential diagnosis

    Chronic obstructive pulmonary disease: dyspnea from airflow limitation, distinguished by obstructive spirometry and a normal natriuretic peptide.

  • Diagnosis

    Establish clinically with supportive natriuretic peptides and echocardiography, then classify by ejection fraction: the diagnostic basis is compatible symptoms and signs with an elevated BNP or…

  • Management

    First-line for HFrEF, start the four foundational therapies, each continued long term and titrated to target dose: An ARNI (sacubitril-valsartan), or an ACE inhibitor (lisinopril 10 to 40 mg PO daily) if an ARNI is not feasible.

  • Complications

    Acute decompensation and recurrent hospitalization.

  • Prognosis

    Improved markedly by guideline-directed therapy in HFrEF.

  • Prevention

    Control blood pressure below 130/80 mmHg.

Read the whole article

Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.